Table 3 Abnormal neuromonitoring and outcome.
Neuromonitoring abnormality (as % of monitoring time) | SAH | TBI | ||||
|---|---|---|---|---|---|---|
Favourable outcome (median, IQR) | Unfavourable outcome (median, IQR) | P-value | Favourable outcome (median, IQR) | Unfavourable outcome (median, IQR) | P-value | |
ICP > 20 mmHg | 1.7 (0.7–3.1) % | 1.9 (1.2–5.8) % | 0.28 | 2.6 (1.5–4.6) % | 1.6 (1.1–3.4) % | 0.32 |
CPP < 60 mmHg | 1.6 (1.4–1.9) % | 4.0 (1.3–6.2) % | 0.11 | 6.3 (3.3–9.5) % | 4.5 (1.9–5.3) % | 0.052 |
PbtO2 < 20 mmHg | 26 (1.4–48) % | 37 (24–63) % | 0.07 | 16% (8.7–32) | 20 (10–43) % | 0.65 |
Metabolic crisis | 9.4 (1.7–25) % | 3.0 (0.35–25) % | 0.67 | 14 (1.9–23) % | 0.91 (0.0–8.4) % | 0.12 |